Specialty Products Top 25% Of Total Rx Spend And Growth To Accelerate – Express Scripts
This article was originally published in The Pink Sheet Daily
Executive Summary
Express Scripts’ annual Drug Trend Report shows cause for continued payer concern about spending on specialty drugs, with those products accounting for nearly 28% of total commercial drug spend in 2013 and projected spending growth of 64% over the next three years.